Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Stephanie Dakin

PhD BVetMed MRCVS PGCert TLHE FHEA


Associate Professor of Musculoskeletal Sciences

  • Versus Arthritis Career Development Fellow
  • Director of Postgraduate Taught Studies MSc MSK Sciences
  • Green Templeton College Research Fellow

BIOGRAPHY


Stephanie graduated as a veterinary surgeon in 2003 from the Royal Veterinary College (RVC), University of London. After undertaking an internship specialising in equine orthopaedics, she then spent 5 years in general practice as an equine veterinary clinician. In 2008, Stephanie commenced a PhD at the RVC researching the role of inflammation in equine tendinopathy, which was successfully completed in 2012. During this time Stephanie also worked as a clinician in an equine hospital. 

Stephanie moved to NDORMS in 2013 to advance and translate her research from horses to humans. She successfully secured consecutive research Fellowships funded by Versus Arthritis (Foundation Fellowship), an Oxford-UCB Prize Fellowship in Biomedical Sciences and more recently a Versus Arthritis Career Development Fellowship. In 2020, Stephanie was appointed tenured Associate Professor of Musculoskeletal Sciences at NDORMS and a Research Fellow at Green Templeton College

Stephanie's research focuses on identifying the mechanisms underpinning the development of chronic inflammatory fibrosis in soft tissue joint disease. The over-arching goal of her research is to discover novel therapeutic strategies to promote resolution of inflammation and fibrosis in chronically inflamed soft tissues, with a particular focus on tendinopathy, frozen shoulder and knee arthrofibrosis. Her key collaborators in the Department are Professor Andrew CarrProfessor Christopher Buckley and Professor Mark Coles. View media associated with Stephanie's work under 'Featured Research'. 

Stephanie is also Director of Postgraduate Taught Studies for the MSc in Musculoskeletal Sciences at the University of Oxford. This part time 2-year course integrating orthopaedics, trauma and rheumatology delivers an internationally renowned programme. For more information on this course see the  Taught MSc in Musculoskeletal Sciences  or contact the Course Administrator. Stephanie obtained PGCert TLHE qualification in 2020 and is recognised as a Fellow of the Higher Education Academy.

DAKIN GROUP: SOFT TISSUE JOINT DISEASE 

RESEARCH VISION AND OBJECTIVES

Soft tissue diseases of the joint present an immense global burden and significant cost to the NHS. Pathologies affecting tendons (tendinopathy), tendon–bone attachments (enthesopathy) and the joint capsule (frozen shoulder and knee arthrofibrosis) are common causes of pain, chronic disability and reduction in life quality, which are exacerbated with ageing. 

Joint soft tissues, including the synovium, capsule, tendon and entheses, are predominantly composed of mesenchymal stromal cells including fibroblasts, tissue-resident macrophages and blood and lymphatic vascular endothelial cells. Our research programmes aim to:

* Identify the cellular & molecular basis of diseases affecting tendons (tendinopathy, tendon tears) and the  joint capsule (frozen shoulder, knee arthrofibrosis)

* Identify new therapeutic strategies to promote resolution of inflammatory fibrosis in these conditions

Research Impacts

Our research will generate new insights into how tissue resident cells of the joint drive chronic inflammation and fibrosis. Findings from this research will advance understanding of how musculoskeletal soft tissue disorders develop and how injured tissues heal. Our research will inform new strategies to treat common musculoskeletal diseases, helping patients keep fit for improved future health.

See more information about the Dakin Group.

Free access

Inflammation activation and resolution in human tendon disease
Dakin et al. 2015
Science Translational Medicine

Abstract
Reprint
Full text 

 

Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy

Dakin et al. 2017

Scientific Reports

Full text

Media

 

Chronic inflammation is a feature of Achilles tendinopathy and rupture

Dakin et al. 2017

British Journal of Sports Medicine

Full text

Pathogenic stromal cells as therapeutic targets in joint inflammation

Dakin et al. 2018

Nature Reviews Rheumatology

Full text

Key publications

Recent publications

More publications